Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, sn Artemisia asiatica extract

World Journal of Gastroenterology

Volumn 11, Issue 47, 2005, Pages 7450-7456

  Oh, Tae Young ^a   Ahn, Gook Jun ^a   Choi, Seul Min ^a   Ahn, Byoung Ok ^a   Kim, Won Bae ^a  

^a Dong A Pharmaceutical Company   (South Korea)

Author keywords

Alcohol; DA 9601; Gastric damage; Glutathione; Malondialdehyde; Myeloperoxidase; Naproxen; NSAIDs; Prostaglandin E2

Indexed keywords

ALCOHOL; ARTEMISIA ASIATICA EXTRACT; DA 9601; GLUTATHIONE; MALONALDEHYDE; MYELOPEROXIDASE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT; PROSTAGLANDIN E2; STILLEN; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTEMISIA; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG MECHANISM; ENZYME ACTIVATION; HISTOPATHOLOGY; MALE; NONHUMAN; RAT; RAT STRAIN; STATISTICAL ANALYSIS; STOMACH INJURY; STOMACH MUCOSA; STOMACH PROTECTION;

EID: 31144458385     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i47.7450     Document Type: Article

References (36)

1. Pilotto A. Aging and upper gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004; 18 (Suppl): 73-81
2. Aihara T, Nakamura E, Amagase K Tomita K, Fujishita T, Furutani K, Okabe S. Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future. Pharmacol Ther 2003; 98: 109-127
3. Behrman SW. Management of complicated peptic ulcer disease. Arch Surg 2005; 140: 201-208
4. Roth SH. From peptic ulcer disease to NSAID gastropathy. An evolving nosology. Drugs Aging 1995; 6: 358-367
5. Appleyard CB, McCafferty DM, Tigley AW, Swain MG, Wallace JL. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am J Physiol 1996; 270: G42-G48
6. Andrews FJ, Malcontenti-Wilson C, O'Brien PE. Effect of nonsteroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa. Am J Physiol 1994; 266: G657-G664
7. Gutthann SP, Garcia Rodriguez LA, Raiford DS. Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology 1997; 8: 18-24
8. Hernandez-Diaz S, Rodriguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000; 160: 2093-2099
9. Weil J, Langman MJ, Wainwright P, Lawson DH, Rawlins M, Logan RF, Brown TP, Vessey MP, Murphy M, Colin-Jones DG. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000; 46: 27-31
10. Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998; 158: 33-39
11. Kaufman DW, Kelly JP, Wiholm BE, Laszlo A, Sheehan JE, Koff RS, Shapiro S. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol 1999; 94: 3189-3196
12. Chan FK. NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management. Drug Saf 2005; 28: 287-300
13. Riezzo G, Chiloiro M, Montanaro S. Protective effect of amtolmetin guacyl versus placebo diclofenac and misoprostol in healthy volunteers evaluated as gastric electrical activity in alcohol-induced stomach damage. Dig Dis Sci 2001; 46: 1797-1804
14. Stern AI, Hogan DL, Isenberg JI. A new method for quantitation of ion fluxes across in vivo human gastric mucosa: effect of aspirin, acetaminophen, ethanol, and hyperosmolar solutions. Gastroenterology 1984; 86: 60-70
15. Seol SY, Kim MH, Ryu JS, Choi MG, Shin DW, Ahn BO. DA-9601 for erosive gastritis: results of a double-blind placebo-controlled phase III clinical trial. World J Gastroeterol 2004; 10: 2379-2382
16. Oh TY, Ryu BK, Yang JI, Kim WB, Park JB, Lee SD, Lee EB. Studies on antiulcer effects of DA-9601, an Artemisia Herba extract, against experimental gastric ulcers and its mechanism. J Appl Pharmacol 1996; 4: 111-121
17. Oh TY, Ahn BO, Ko JI, Ryu BK, Son MW, Kim SH, Kim WB, Lee WB. Studies on protective effect of DA-9601, an Artemisiae herba extract, against ethanol-induced gastric mucosal damage and its mechanism. J Appl Pharmacol 1997; 5: 202-210
18. Griffin MR, Smalley WE. Drugs and ulcers: clues about mucosal protection from epidemiologic studies. J Clin Gastroenterol 1995; 21 Suppl 1: S113-S119
19. Oates PJ, Hakkinen JP. Studies on the mechanism of ethanol-induced gastric damage in rats. Gastroenterology 1988; 94: 10-21
20. Nakagawa S. Relationship between histological gastritis and mucosal microvascular observations using magnifying endoscopy. Hokkaido Igaku Zasshi 2003; 78: 349-356
21. Silen W. Experimental models of gastric ulceration and injury. Am J Physiol 1988; 255: G395-G402
22. Miller DA, Chernin VV, Tkachev VA, Matiash BL. Microcirculation in patients with chronic gastritis depending on its exacerbation severity and morphological type. Eksp Min Gastroenterol 2002; 4: 14-17
23. Garner A. Adaptation in the pharmaceutical industry, with particular reference to gastrointestinal drugs and diseases. Scand J Gastroenterol Suppl 1992; 193: 83-89
24. Peng S, Duggan A. Gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf 2005; 4: 157-169
25. McCafferty DM, Granger DN, Wallace JL. Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats. Gastroenterology 1995; 109: 1173-1180
26. Miedzybrodzki R. Trends in nonsteroidal anti-inflammatory drug development and application. Postepy Hig Med Dosw(Online) 2004; 58: 438-448
27. Cuzzolin L, Conforti A, Adami A, Lussignoli S, Menestrina F, Del Soldato P, Benoni G. Anti-inflammatory potency and gastrointestinal toxicity of a new compound, nitronaproxen. Pharmacol Res 1995; 31: 61-65
28. Reuter BK, Cirino G, Wallace JL. Markedly reduced intestinal toxicity of a diclofenac derivative. Life Sci 1994; 55: PL1-PL8
29. Onoe Y, Miyaura C, Kaminakayashiki T, Nagai Y, Noguchi K, Chen QR, Seo H, Ohta H, Nozawa S, Kudo I, Suda T. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J Immunol 1996; 156: 758-764
30. Slater DM, Berger LC, Newton R, Moore GE, Bennett PR. Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term. Am J Obstet Gynecol 1995; 172: 77-82
31. Hudson N, Balsitis M, Everitt S, Hawkey CJ. Enhanced gastric mucosal leukotriene B4 synthesis in patients taking nonsteroidal anti-inflammatory drugs. Gut 1993; 34: 742-747
32. Wallace JL, McCafferty DM, Carter L, McKnight W, Argentieri D. Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: anti-inflammatory without gastropathy? Gastroenterology 1993; 105: 1630-1636
33. Vaananen PM, Keenan CM, Grisham MB, Wallace JL. Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy. Inflammation 1992; 16: 227-240
34. Lanas A. Prevention and treatment of non-steroidal antiinflammatory drug gastroenteropathy. Rev Gastroenterol Mex 2004; 69: 251-260
35. Demir S, Yilmaz M, Koseoglu M, Akalin N, Aslan D, Aydin A. Role of free radicals in peptic ulcer and gastritis. Turk J Gastroenterol 2003; 14: 39-43
36. Perry MA, Wadhwa S, Parks DA, Pickard W, Granger DN. Role of oxygen radicals in ischemia-induced lesions in the cat stomach. Gastroenterology 1986; 90: 362-267